BACKGROUND: Tracheomalacia (TM) occurs in approximately 1 in 2,100 children. Because the trachea develops abnormally in animal models of cystic fibrosis (CF), we hypothesized this may also occur in children with CF, increasing their risk of TM. PURPOSE: To examine the prevalence and clinical consequences of TM in children with CF. METHODS: We studied children with CF born between 1995 and 2012. TM was defined as dynamic collapse of the trachea, and the severity was recorded as described in the chart. The effect of TM on patient outcomes, including FEV1 , CT changes, and acquisition of CF pathogens, was assessed using a longitudinal patient dataset. RESULTS: Eighty-nine percent of children with CF had at least one bronchoscopy (n = 97/109). Fifteen percent of these children had TM described in any bronchoscopy report (n = 15/97). Of the patients with TM, eight had meconium ileus (P = 0.003) and all were pancreatic insufficient. Pseudomonas aeruginosa infection occurred 1.3 years earlier among children with TM (P = 0.01). Starting FEV1 values by age 8 were diminished by over 18% of predicted for patients with TM. Life-threatening episodes of airway obstruction occurred in 3 of 15 patients with CF and TM, including one leading to death. Gender, prematurity, and hepatic disease were not associated with TM. No difference was observed in the frequency of bronchiectasis. CONCLUSIONS: TM is significantly more common in infants and children with CF than in the general population and is associated with airway obstruction and earlier Pseudomonas acquisition.
BACKGROUND:Tracheomalacia (TM) occurs in approximately 1 in 2,100 children. Because the trachea develops abnormally in animal models of cystic fibrosis (CF), we hypothesized this may also occur in children with CF, increasing their risk of TM. PURPOSE: To examine the prevalence and clinical consequences of TM in children with CF. METHODS: We studied children with CF born between 1995 and 2012. TM was defined as dynamic collapse of the trachea, and the severity was recorded as described in the chart. The effect of TM on patient outcomes, including FEV1 , CT changes, and acquisition of CF pathogens, was assessed using a longitudinal patient dataset. RESULTS: Eighty-nine percent of children with CF had at least one bronchoscopy (n = 97/109). Fifteen percent of these children had TM described in any bronchoscopy report (n = 15/97). Of the patients with TM, eight had meconium ileus (P = 0.003) and all were pancreatic insufficient. Pseudomonas aeruginosainfection occurred 1.3 years earlier among children with TM (P = 0.01). Starting FEV1 values by age 8 were diminished by over 18% of predicted for patients with TM. Life-threatening episodes of airway obstruction occurred in 3 of 15 patients with CF and TM, including one leading to death. Gender, prematurity, and hepatic disease were not associated with TM. No difference was observed in the frequency of bronchiectasis. CONCLUSIONS: TM is significantly more common in infants and children with CF than in the general population and is associated with airway obstruction and earlier Pseudomonas acquisition.
Authors: Ruben Boogaard; Sjoerd H Huijsmans; Marielle W H Pijnenburg; Harm A W M Tiddens; Johan C de Jongste; Peter J F M Merkus Journal: Chest Date: 2005-11 Impact factor: 9.410
Authors: Shaunagh McDermott; Sinead C Barry; Eoin P Judge; Eoin E Judge; Susan Collins; Pim A de Jong; Harm A W M Tiddens; Edward F McKone; Charles C Gallagher; Jonathan D Dodd Journal: Radiology Date: 2009-06-09 Impact factor: 11.105
Authors: Peter D Sly; Catherine L Gangell; Linping Chen; Robert S Ware; Sarath Ranganathan; Lauren S Mott; Conor P Murray; Stephen M Stick Journal: N Engl J Med Date: 2013-05-23 Impact factor: 91.245
Authors: Amit Diwakar; Ryan J Adam; Andrew S Michalski; Monelle M Tamegnon; Anthony J Fischer; Jan L Launspach; Rebecca A Horan; Simon C Kao; Kathryn Chaloner; David K Meyerholz; David A Stoltz Journal: Laryngoscope Date: 2015-03-30 Impact factor: 3.325
Authors: Ryan J Adam; Mahmoud H Abou Alaiwa; Drake C Bouzek; Daniel P Cook; Nicholas D Gansemer; Peter J Taft; Linda S Powers; Mallory R Stroik; Mark J Hoegger; James D McMenimen; Eric A Hoffman; Joseph Zabner; Michael J Welsh; David K Meyerholz; David A Stoltz Journal: J Appl Physiol (1985) Date: 2017-06-15
Authors: Ammar Saadoon; Namasivayam Ambalavanan; Kurt Zinn; Ambika P Ashraf; Mark MacEwen; Teodora Nicola; Michelle V Fanucchi; William T Harris Journal: Am J Respir Cell Mol Biol Date: 2017-03 Impact factor: 6.914
Authors: Ryan J Adam; Katherine B Hisert; Jonathan D Dodd; Brenda Grogan; Janice L Launspach; Janel K Barnes; Charles G Gallagher; Jered P Sieren; Thomas J Gross; Anthony J Fischer; Joseph E Cavanaugh; Eric A Hoffman; Pradeep K Singh; Michael J Welsh; Edward F McKone; David A Stoltz Journal: JCI Insight Date: 2016-04-07
Authors: Ryan J Adam; Andrew S Michalski; Christian Bauer; Mahmoud H Abou Alaiwa; Thomas J Gross; Maged S Awadalla; Drake C Bouzek; Nicholas D Gansemer; Peter J Taft; Mark J Hoegger; Amit Diwakar; Matthias Ochs; Joseph M Reinhardt; Eric A Hoffman; Reinhard R Beichel; David K Meyerholz; David A Stoltz Journal: Am J Respir Crit Care Med Date: 2013-12-15 Impact factor: 21.405
Authors: Erik B Hysinger; Alister J Bates; Nara S Higano; Dan Benscoter; Robert J Fleck; Catherine K Hart; Gregory Burg; Alessandro De Alarcon; Paul S Kingma; Jason C Woods Journal: Chest Date: 2019-12-17 Impact factor: 9.410
Authors: Emily M DeBoer; Julia S Kimbell; Kaci Pickett; Joseph E Hatch; Kathryn Akers; John Brinton; Graham L Hall; Louise King; Fiona Ramanauskas; Tim Rosenow; Stephen M Stick; Harm A Tiddens; Thomas W Ferkol; Sarath C Ranganathan; Stephanie D Davis Journal: Respir Physiol Neurobiol Date: 2021-06-19 Impact factor: 1.931